Tag : Rituximab

Gastroenterology

Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia

Newsemia
Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia Source link...
Latest News

Janssen busca ampliar el uso de IMBRUVICA® (ibrutinib) en combinación con rituximab para pacientes con leucemia linfocítica crónica (LLC) no tratada con anterioridad

Newsemia
BEERSE, Bélgica–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson ha anunciado hoy la presentación de una solicitud de variación de Tipo II a la...
Neurology

Negative Phase 2 Trial Data Ends Development of PSP Drug

Newsemia
Phase 2 trial results show gosuranemab did not meet primary or key secondary endpoints in patients with progressive supranuclear palsy, leading to discontinuation of the...
Latest News

Irutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Newsemia
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced results from an extended follow-up analysis of patients in its randomized Phase 3 clinical trial, E1912. Source...
Pharma / Biotech

Synthesis and preliminary evaluation of 99mTc-Hynic-fragments [F(ab')2 and F(ab')] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin's lymphoma.

Newsemia
Synthesis and preliminary evaluation of 99mTc-Hynic-fragments [F(ab’)2 and F(ab’)] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin’s lymphoma. Appl Radiat Isot. 2019 Jul 12;153:108808...
Latest News

Phase III PEMPHIX Study Showed That Genentech’s Rituxan (Rituximab) is Superior to Standard of Care in Achieving Sustained Remission in Patients with Pemphigus Vulgaris

Newsemia
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive top line results from the Roche-sponsored...
Latest News

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Newsemia
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a...
Latest News

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases

Newsemia
Pan, S; Yu, H; Surti, A; Cheng, I; Marks, SD; Brogan, PA; Eleftheriou, D; Pan, S; Yu, H; Surti, A; Cheng, I; Marks, SD; Brogan,...
Neurology

PREVENT: Eculizumab May Lower Relapse Risk in NMOSD

Newsemia
Use of eculizumab resulted in significantly greater relapse reduction over placebo in patients with neuromyelitis optica spectrum disorder (NMSOD), new findings from the phase 3...
Neurology

Off-Label Drug Research Generates 'Medical Uncertainty'

Newsemia
Research that explores/supports off-label use of pregabalin and other medications may be misleading if early promising results are not subsequently validated, investigators suggest in a...
Neurology

Anti-CGRP Monoclonal Antibodies for Migraine Prevention

Newsemia
Dr Deborah Friedman reviews the new anti-CGRP monoclonal antibodies for migraine prevention. American Headache Society and Medscape Source link...
Latest News

Celltrion Healthcare présente des résultats positifs pour le CT-P10, un biosimilaire du rituximab, dans le traitement du lymphome folliculaire à un stade avancé à l’occasion du congrès 2018 de la Société américaine d'hématologie

Newsemia
SAN DIEGO–(BUSINESS WIRE)–Celltrion Healthcare a présenté aujourd’hui de nouvelles données à l’occasion du congrès 2018 de la Société américaine d’hématologie (ASH), qui montrent que l’efficacité...
Latest News

Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting

Newsemia
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced today at the American Society of Hematology Annual Meeting that the REFLECTIONS B328-06 study, a comparative safety and efficacy...
Neurology

Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review.

Newsemia
Related Articles Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review. J Neuroimmunol. 2018 Nov 14;326:28-32 Authors: Bouxin M,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy